Synovial sarcoma future or investigational therapies

Synovial sarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Synovial sarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Immunohistochemical Techniques
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Synovial sarcoma future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Synovial sarcoma future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Synovial sarcoma future or investigational therapies
CDC on Synovial sarcoma future or investigational therapies
Synovial sarcoma future or investigational therapies in the news
Blogs on Synovial sarcoma future or investigational therapies
Directions to Hospitals Treating Synovial sarcoma
Risk calculators and risk factors for Synovial sarcoma future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Further investigation of the molecular mechanisms underlying SYT-SSX function will likely lead to not only a better understanding of this disease but improved diagnostic and treatment tools for this tumor.